Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

REPLIGEN CORP Director's Dealing 2016

May 13, 2016

30826_dirs_2016-05-13_3d42cad1-e129-4500-a9b5-06031bedf908.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: REPLIGEN CORP (RGEN)
CIK: 0000730272
Period of Report: 2016-05-11

Reporting Person: RYAN THOMAS F JR (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2016-05-11 Common Stock A 1763 Acquired 22094 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2016-05-11 Stock Option (Right to Buy) $26.12 A 3366 Acquired 2026-05-11 Common Stock (3366) Direct

Footnotes

F1: Mr. Ryan was awarded 1,763 Restricted Stock Units. Each Restricted Stock Unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The Restricted Stock Units vest on May 11, 2017. The Restricted Stock Units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.

F2: Award vests in full one year from grant date on May 11, 2017.